More articles about: Gastroenterology

In this Q&A, a Michigan Medicine doctor talks about esophageal cancer, its signs and risk factors to know.

Michigan Medicine hepatologists are preparing a year-long study looking at the techniques cirrhosis patients can use at home to relieve chronic pain without medication.

Study finds the DILI-Inpt prognostic score outperformed existing systems in identifying which hospitalized patients with severe idiosyncratic drug-induced liver injury were unlikely to recover on their own.

ALOX15 loss, which is common in colorectal tumors, impairs the cancer-preventative effects of fish oil. Read the full article on Health Lab.

Reddit’s popularity as a tool for self managing inflammatory bowel disease highlights opportunities for improvements in clinical care, according to a paper published in Journal of Medical Internet Research.

A patient found help with her irritable bowl syndrome, also known as IBS, with gastrointestinal behavioral therapy at Michigan Medicine.

An international research team finds that the human gut is a site of rapid change, with recent and important deviations from other mammals.

In a new study, patients with irritable bowel syndrome with diarrhea, or IBS-D, who went on a low FODMAP diet saw an improvement of colonic barrier dysfunction, commonly known as “leaky gut.”

A pilot study found that the Mediterranean diet may provide symptom relief for people with irritable bowel syndrome commonly referred to as IBS.

Researchers used mouse models and studies of colorectal cancer tissues to show that loss of SOX9 gene promotes tumor progression and the pathway it regulates can be a potential target for future treatments.

The FDA approved a device developed at the University of Michigan that allows doctors to diagnose and predict treatment outcomes for individuals with chronic constipation far earlier than other methods.

Michigan Medicine becomes leader in treating severe ulcerative colitis with JAK inhibitors.

Research from Michigan Medicine investigated possible genetic factors for drug efficacy for children with Crohn’s disease. 

Early treatment of pediatric Crohn’s disease with anti-tumor necrosis factor medications can substantially reduce the risk of perianal fistulas in Crohn’s disease. Michigan Medicine researchers confirmed this finding using prospective data. 

Newly presented data suggest that infants who receive a hybrid stage I palliation – a less invasive alternative for initial treatment – more commonly develop necrotizing enterocolitis compared to those who receive the standard Norwood operation, a complex open heart surgery.